Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.

Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.

Item
http://www.wikidata.org/entity/Q50699776
A Dormant Microbial Component in the Development of PreeclampsiaPotential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.Characteristics, treatments, and outcomes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011-2013.Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in JapanEfficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case reportRevision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide surveyEffects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.Adsorption of Nafamostat Mesilate on AN69ST Membranes: A Single-Center Retrospective and In Vitro Study.Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction.Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective studyCirculating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulinDifferences and similarities between disseminated intravascular coagulation and thrombotic microangiopathyTreatment of patients with sepsis in a closed intensive care unit is associated with improved survival: a nationwide observational study in Japan
P2860

Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.

Item
http://www.wikidata.org/entity/Q50699776
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Recombinant human soluble thro ...... lticentre retrospective study.
@en
Recombinant human soluble thro ...... lticentre retrospective study.
@nl
type
label
Recombinant human soluble thro ...... lticentre retrospective study.
@en
Recombinant human soluble thro ...... lticentre retrospective study.
@nl
prefLabel
Recombinant human soluble thro ...... lticentre retrospective study.
@en
Recombinant human soluble thro ...... lticentre retrospective study.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Recombinant human soluble thro ...... lticentre retrospective study.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921